Quidel Corporation (QDEL) stock is soaring 7.18% in pre-market trading on Monday, as investors react positively to a new trade agreement between the United States and China. The deal, which aims to slash tariffs, has sparked a broad rally across the life sciences sector.
The US-China trade agreement is expected to significantly benefit companies in the life sciences industry, potentially reducing costs and improving access to the Chinese market. Quidel, a prominent player in the diagnostic healthcare products market, is among several companies in the sector seeing substantial gains.
Other major players in the life sciences industry are also experiencing notable increases in their stock prices. Bio-Techne is up 6.1%, Bio-Rad Laboratories has risen 5.9%, and Thermo Fisher Scientific has gained 4.7%. This sector-wide rally underscores the potential impact of the trade deal on companies involved in medical research, diagnostics, and healthcare technology.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。